(A) Gender composition of participants in the mPower walking test.
(B) Age composition of participants in the mPower walking test.
(C) Age and PD patients/healthy controls distribution in male and female participants and comparison of AUROCs when our model is performed on either a male or female cohort in 5-fold cross-validation.
(D) Age and PD patients/healthy controls distribution in ourdataset and comparison of AUROCs when our model is performed on participants aged under 45 (<45), aged between 45 and 70 (45–70), and aged over 70 (≥70) years in 5-fold cross-validation.